Table 1.
Effect of phosphorylation by cdk5, GSK-3 or cdk5 plus GSK-3 on the binding of different free or MT-bound tau isoforms to microtubules
| τ isoform used | Kinase used (1st, 2nd) | τ bound to MT (%)(phosphorylation of τ followed by binding to MT) | τ remained bound to MT (%)(phosphorylation of MT-bound τ) |
|---|---|---|---|
| τ3 | – | 100 ± 2 | 100 ± 2 |
| –, cdk5 | 98 ± 4 | 92 ± 3 | |
| –, GSK-3 | 89 ± 2 | 86 ± 2 | |
| cdk5, GSK-3 | 60 ± 4* | 76 ± 1* | |
| τ4 | – | 100 ± 2 | 100 ± 3 |
| –, cdk5 | 96 ± 2 | 92 ± 3 | |
| –, GSK-3 | 87 ± 2 | 86 ± 2 | |
| cdk5, GSK-3 | 56 ± 4* | 75 ± 3* | |
| τ3L | – | 100 ± 2 | 100 ± 3 |
| –, cdk5 | 93 ± 3 | 88 ± 2 | |
| –, GSK-3 | 89 ± 2 | 81 ± 2 | |
| cdk5, GSK-3 | 21 ± 3** | 51 ± 5** | |
| τ4L | – | 100 ± 3 | 100 ± 2 |
| –, cdk5 | 95 ± 2 | 88 ± 2 | |
| –, GSK-3 | 89 ± 2 | 81 ± 3 | |
| cdk5, GSK-3 | 19 ± 4** | 54 ± 4** |
p<0.05;
p<0.01